#IGTPnews this week? 🔹 New evidence on the therapeutic potential of EVs in kidney injury 🔹 IGTP drives collaborative science in health with three @PpccSalud projects 🔹 The CARE Annual Meeting reviews the program’s activity and future plans Read more: https://t.co/vJC2czUyJD

👥 Ahir, el III CARE Annual Meeting va reunir la comunitat de recerca en càncer del #CampusCanRuti en una jornada centrada en el diàleg científic, la interdisciplinarietat i l’estratègia de futur Descobreix més sobre l’esdeveniment 👉🏼 https://t.co/m5Aqm1SWEE

🗳️ Lessons from the Tennessee Special Election Breaking down the lessons from the Tennessee special election, what Republicans have to be enthusiastic about, and what adjustments they’ll make going into the midterms.

👥 Yesterday, the III CARE Annual Meeting brought together the cancer research community of #CampusCanRuti for a day focused on scientific dialogue, interdisciplinarity and future strategy Learn more about the event 👉🏼 https://t.co/J1zxAXuFaH

🌿💫 Aquest Nadal fem realitat el Jardí dels Sentits, una iniciativa d'#AmicsdeCanRuti i @hgermanstrias per crear un nou espai terapèutic a l’aire lliure que transformi l’experiència hospitalària Coneix-ne més 👉🏼 https://t.co/dHBJDwCGzf Col·labora-hi 👉🏼 https://t.co/lQVRzxX14o

🚀 Exciting news for GCAT and IGTP! We are proud to have contributed to three projects within the Complementary Plan for Biotechnology Applied to Health: ✅ IA4T2D ✅ InMaM ✅ DATOS-CA 👏 A big thank you to all partners for making this possible!

When those who govern direct public attention toward threats of minimal consequence whilst ignoring dangers of far greater magnitude, the citizen must ask: To what end? The answer is rarely ignorance. It is strategy. Vulnerable groups make convenient scapegoats. Complex,

🏃🏽‍♂️🏃🏻‍♀️ La Cursa Benèfica Malalties Minoritàries torna el del 22 de febrer de 2026! Les inscripcions ja estan obertes 👉🏼 https://t.co/RP9IWjOO3l En benefici de la recerca en malalties neuromusculars i neuropediàtriques 👉🏼 https://t.co/6CwvnPGe2l @AccioBadalona @AjBadalona

The #CMCiB hosted part of the validation phases of the non-invasive Histotripsy Platform developed by @histosonics, for liver tumour treatment 🎥 Carolina Alemany, Clinical and R&D engineer at @histosonics, shares her experience 🔗Discover more: https://t.co/h5ekKa5IwU

🆕 L’IGTP impulsa la ciència col·laborativa en salut després de tres anys de cooperació en biotecnologia Amb tres projectes dins del Pla Complementari de Biotecnologia aplicada a la Salut @PpccSalud, que tanca la seva primera edició Més informació: https://t.co/3f9XO5j6CE

🆕 IGTP drives collaborative science in health after three years of cooperation in biotechnology With three projects within the Complementary Plan for Biotechnology Applied to Health @PpccSalud, which has just completed its first edition Read more: https://t.co/PlHmlTDT3O

SCOOP: Sources involved in the @wbd bidding war say the company has asked for a third-round of bids from @paramountco - @Skydance @netflix and @comcast due today. Story developing

🗓️ L'última sessió Susie Bayarri de l'any es celebrarà el 18 de desembre, tractant mètodes d'emparellament per controlar la confusió en estudis observacionals Si estàs interessat en la bioestadística o la metodologia de recerca en salut, apunta't aquí: https://t.co/yJdMt2MSsU

🔸 The CARE community has come together to hear from its young researchers ahead of the meeting at @BCIN95 Looking forward to the sessions tomorrow!

RUSH-PoCTest, un projecte innovador impulsat des de l'IGTP, ha estat un dels 20 seleccionats a la darrera convocatòria de subvencions de PERIS 2022-2027 @salutcat Es tracta d'un test per al diagnòstic de l'ictus isquèmic en entorns prehospitalaris 🚑 🔗 https://t.co/mFOvMUahCI

🦠#ENDVOC researchers at @GTRecerca and #ISGlobal have discovered that the sequence of diseases a person experienced before #SarsCov2 infection influences their risk of developing #LongCOVID. 🔎By analysing data from the COVICAT cohort, the study has revealed previously

CyberX What do you think? @elonmusk @TeslaBoomerMama @herbertong @CernBasher

Excited to share our new paper on how Dialister and succinate may drive inflammation and postoperative recurrence in Crohn’s disease. Validated in two independent cohorts (@hjoan23 & @GTRecerca). Thanks @Geteccu! 🔗 https://t.co/YQv8MdKssD #CrohnsDisease #microbiota #metabolite

In today's Coffee Talk session, Daria Smalchuk (@Oneandahalf_Lab) has explained her research on mycobacteriophages as an adjunct therapy #IGTPCoffeeTalks

@FundlaCaixa @IrsiCaixa @EsantosE @BeaMothe @angelfont @CaixaForum 6/La Dra. Julia García Prado destacó 3 hitos en la investigación del VIH: 1.Identificar el virus 2.Desarrollar tratamientos que reducen la carga viral hasta hacerla indetectable 3.Confirmar que si es indetectable, no se transmite  ¿El gran reto ahora? Crear una cura y una

.@GTRecerca New evidence on the therapeutic potential of extracellular vesicles in kidney injury https://t.co/iYNVdLt2EQ

Join the Light Meets Insight Challenge! Campaign: Dec 3–Jan 9 Prize: Top 5 stories win a ScreenBar Halo 2 How to participate: 1. Post a photo or short insight moment on X 2. Tag & follow @BenQAmerica 3. Use the hashtags LightMeetsInsight & BenQScreenBar

🆕 Investigadors de l’IGTP han analitzat el potencial terapèutic de les vesícules extracel·lulars derivades de cèl·lules mare mesenquimals per abordar el dany renal 🗞️ Estudi publicat a la revista @VesiclesAcids i destacat com a portada Més informació: https://t.co/NNIgGottOZ

🆕 Researchers from IGTP have analysed the therapeutic potential of extracellular vesicles derived from mesenchymal stem cells to address kidney injury 🗞️ Study published in the journal @VesiclesAcids and featured on the cover Read more: https://t.co/kDRvPxenVt

📢 Do not miss the Coffee Talk taking place tomorrow, discussing the potential of mycobacteriophages as an adjunct therapy More information: https://t.co/4815fhJ7kD #IGTPCoffeeTalks